My colleagues found a way to raise my blood pressure this morning. I woke up and saw that our resident car designer, Adrian, had thrown a link into Slack going to an article about some random woman on ...

Add articles to your saved list and come back to them any time. Marnus Labuschagne has been told to free himself of his self-imposed shackles in his quest to rediscover the form that made him ...

One of the biggest risk factors for developing liver cancer is a high-fat diet. A new study from MIT reveals how a fatty diet rewires liver cells and makes them more prone to becoming cancerous. The ...

Besides convenience, one of the main benefits of self-driving cars is supposed to be safety. Yet in a bizarre move, Waymo — whose self-driving cabs had been enjoying extraordinary safety metrics — has ...

GLP-1 is the naturally produced hormone whose function is being mimicked by drugs like semaglutide and tirzepatide, the active ingredients in popular and highly effective weight-loss drugs like Wegovy ...

The purpose of this article is to evaluate the PCM Fund (PCM) as an investment option at its current market price. This is a closed-end fund whose investment objective is "to seek high current income" ...

Nov. 6—The PCM football team is back in a familiar position this season. The Class 2A No. 2 Mustangs are one win away from their second straight state semifinal and standing in the way is Wilton, ...

Pregnancy and breastfeeding leave behind long-lived CD8+ T lymphocytes that provide lasting immune protection in breast tissue, according to new research, a discovery that could reshape understanding ...

The cost of sequencing DNA has dropped dramatically, and with technologies like CRISPR, gene editing is becoming more precise and powerful than ever. From curing genetic diseases to designing the next ...

Cancer cells can brainwash their neighbors. Like the CIA deploying secret agents to turn an enemy, tumors use a similar strategy to manipulate nearby cells. The tumors’ agents are mitochondria, the ...

A first-in-class antisense oligonucleotide — RES-010 (Resalis Therapeutics, Turin, Italy) — may complement and enhance the efficacy of antiobesity drugs such as GLP-1 receptor agonists (RAs), ...